The full edition of the report is available at Xinhua Silk Road Database. You can click the “Table of Content” to have a general understanding of it.
Click on the button below to create your account and get immediate access to thousands of articles.
China's biopharmaceutical firm Henlius sees annual revenue up 186.3 pct in 2021
Shanghai Henlius Biotech, Inc. (2696.HK), a biopharmaceutical company in east China's Shanghai, announced on Wednesday that its annual revenue in 2021 reached around 1.68 billion yuan (about 265.04 million U.S. dollars), up 186.3 percent year on year, reported China Securities Journal on Thursday.
March18,2022
If you have any questions, please enter them in the box below.
Do you want to be a contributor to Xinhua Silk Road and tell us your Belt & Road story? Send your articles to silkroadweekly@xinhua.org and share your stories with more people.
Click on the button below to create your account and get im http://img.silkroad.news.cn/templates/silkroad/en2017te access to thousands of articles.
